硫酸乙酰肝素在炎症中的作用，以及仿生学作为抗炎策略的发展。
The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies.
机构信息
Graduate School of Biomedical Engineering, University of New South Wales Sydney, Sydney, New South Wales, Australia.
Raymond Purves Bone and Joint Research Laboratory, Kolling Institute, Northern Sydney Local Health District, St. Leonards, New South Wales, Australia.
出版信息
J Histochem Cytochem. 2018 Apr;66(4):321-336. doi: 10.1369/0022155417740881. Epub 2018 Jan 1.
Abstract
Key events that occur during inflammation include the recruitment, adhesion, and transmigration of leukocytes from the circulation to the site of inflammation. These events are modulated by chemokines, integrins, and selectins and the interaction of these molecules with glycosaminoglycans, predominantly heparan sulfate (HS). The development of HS/heparin mimetics that interfere or inhibit the interactions that occur between glycosaminoglycans and modulators of inflammation holds great potential for use as anti-inflammatory therapeutics. This review will detail the role of HS in the events that occur during inflammation, their interaction and modulation of inflammatory mediators, and the current advances in the development of HS/heparin mimetics as anti-inflammatory biotherapeutics.
摘要
在炎症发生过程中会发生一些关键事件，包括白细胞从血液循环招募、黏附和迁移至炎症部位。这些事件受趋化因子、整合素和选择素的调节，这些分子与糖胺聚糖（主要是肝素硫酸酯（HS））相互作用。开发可干扰或抑制糖胺聚糖与炎症调节剂之间相互作用的 HS/肝素类似物，具有作为抗炎治疗药物的巨大潜力。这篇综述将详细介绍 HS 在炎症发生过程中所发生的作用、它们与炎症介质的相互作用和调节，以及作为抗炎生物治疗药物开发 HS/肝素类似物的最新进展。
相似文献
1
The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies.硫酸乙酰肝素在炎症中的作用，以及仿生学作为抗炎策略的发展。
J Histochem Cytochem. 2018 Apr;66(4):321-336. doi: 10.1369/0022155417740881. Epub 2018 Jan 1.
2
Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.与糖胺聚糖相互作用的蛋白质小分子抑制剂（SMIGs），一类具有抗炎特性的新型生物活性剂。
Biochim Biophys Acta. 2014 Jan;1840(1):245-54. doi: 10.1016/j.bbagen.2013.09.023. Epub 2013 Sep 21.
3
Heparan Sulfate Proteoglycans as Relays of Neuroinflammation.硫酸乙酰肝素蛋白聚糖作为神经炎症的传递者。
J Histochem Cytochem. 2018 Apr;66(4):305-319. doi: 10.1369/0022155417742147. Epub 2018 Jan 1.
4
Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses.硫酸乙酰肝素抑制剂及其在炎症性疾病中的治疗意义。
Expert Opin Ther Targets. 2013 Aug;17(8):965-75. doi: 10.1517/14728222.2013.811491. Epub 2013 Jun 24.
5
Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation.糖胺聚糖和糖胺聚糖类似物在癌症和炎症中的作用。
Int J Mol Sci. 2019 Apr 22;20(8):1963. doi: 10.3390/ijms20081963.
6
Glycosaminoglycans and the regulation of allergic inflammation.糖胺聚糖与过敏性炎症的调节
Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):221-5. doi: 10.2174/1568010043343589.
7
Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?我们能否以“大自然”为金标准来生产肝素/硫酸乙酰肝素仿生材料？
Molecules. 2015 Mar 5;20(3):4254-76. doi: 10.3390/molecules20034254.
8
The role of heparan sulphate in inflammation.硫酸乙酰肝素在炎症中的作用。
Nat Rev Immunol. 2006 Sep;6(9):633-43. doi: 10.1038/nri1918. Epub 2006 Aug 18.
9
Synthesized Heparan Sulfate Competitors Attenuate Pseudomonas aeruginosa Lung Infection.合成的肝素硫酸盐竞争物可减轻铜绿假单胞菌肺部感染。
Int J Mol Sci. 2018 Jan 9;19(1):207. doi: 10.3390/ijms19010207.
10
The Challenge of Modulating Heparan Sulfate Turnover by Multitarget Heparin Derivatives.多靶点肝素衍生物调控硫酸乙酰肝素代谢的挑战。
Molecules. 2020 Jan 17;25(2):390. doi: 10.3390/molecules25020390.
引用本文的文献
1
High-Resolution Correlative Microscopy Approach for Nanobio Interface Studies of Nanoparticle-Induced Lung Epithelial Cell Damage.用于纳米颗粒诱导的肺上皮细胞损伤的纳米生物界面研究的高分辨率相关显微镜方法
ACS Nano. 2025 May 20;19(19):18227-18243. doi: 10.1021/acsnano.4c17838. Epub 2025 May 9.
2
Synthesis of Sulfated Carbohydrates - Glycosaminoglycans.硫酸化碳水化合物——糖胺聚糖的合成
Handb Exp Pharmacol. 2025;288:39-54. doi: 10.1007/164_2025_742.
3
Manner of death prediction: A machine learning approach to classify suicide and non-suicide using blood metabolomics.死亡方式预测：一种利用血液代谢组学对自杀和非自杀进行分类的机器学习方法。
Forensic Sci Int Synerg. 2025 Feb 24;10:100580. doi: 10.1016/j.fsisyn.2025.100580. eCollection 2025 Jun.
4
A Network Pharmacology Study and Experimental Validation to Identify the Potential Mechanism of Heparan Sulfate on Alzheimer's Disease-Related Neuroinflammation.一项网络药理学研究及实验验证，以确定硫酸乙酰肝素对阿尔茨海默病相关神经炎症的潜在作用机制。
Biomedicines. 2025 Jan 5;13(1):103. doi: 10.3390/biomedicines13010103.
5
Data-independent acquisition-based blood proteomics unveils predictive biomarkers for neonatal necrotizing enterocolitis.基于数据非依赖采集的血液蛋白质组学揭示了新生儿坏死性小肠结肠炎的预测生物标志物。
Anal Bioanal Chem. 2025 Jan;417(1):199-218. doi: 10.1007/s00216-024-05637-7. Epub 2024 Nov 20.
6
Multi-Omics Profiles of Small Intestine Organoids in Reaction to Breast Milk and Different Infant Formula Preparations.母乳及不同婴儿配方奶对小肠类器官的多组学影响
Nutrients. 2024 Sep 2;16(17):2951. doi: 10.3390/nu16172951.
7
A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils.带电荷的抗α-突触核蛋白抗体的尾部不会增强其与α-突触核蛋白纤维的亲和力。
PLoS One. 2024 Aug 29;19(8):e0308521. doi: 10.1371/journal.pone.0308521. eCollection 2024.
8
Syndecan 4 is a marker of endothelial inflammation in pathological aging and predicts long-term cardiovascular outcomes in type 2 diabetes.Syndecan 4是病理性衰老中内皮炎症的标志物，并可预测2型糖尿病患者的长期心血管结局。
Diabetol Metab Syndr. 2024 Aug 20;16(1):203. doi: 10.1186/s13098-024-01431-8.
9
Leveraging Tunable Nanoparticle Surface Functionalization to Alter Cellular Migration.利用可调谐纳米颗粒表面功能化改变细胞迁移。
ACS Nanosci Au. 2024 Feb 14;4(3):205-215. doi: 10.1021/acsnanoscienceau.3c00055. eCollection 2024 Jun 19.
10
Therapeutic development targeting host heparan sulfate proteoglycan in SARS-CoV-2 infection.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染中宿主硫酸乙酰肝素蛋白聚糖的治疗性开发。
Front Med (Lausanne). 2024 Mar 27;11:1364657. doi: 10.3389/fmed.2024.1364657. eCollection 2024.
本文引用的文献
1
CCL2 nitration is a negative regulator of chemokine-mediated inflammation.CCL2 的硝化作用是趋化因子介导炎症的负调节剂。
Sci Rep. 2017 Mar 14;7:44384. doi: 10.1038/srep44384.
2
Heparanase Mediates Intestinal Inflammation and Injury in a Mouse Model of Sepsis.乙酰肝素酶在脓毒症小鼠模型中介导肠道炎症和损伤。
J Histochem Cytochem. 2017 Apr;65(4):241-249. doi: 10.1369/0022155417692536. Epub 2017 Feb 7.
3
Chemokine CXCL1 mediated neutrophil recruitment: Role of glycosaminoglycan interactions.趋化因子 CXCL1 介导的中性粒细胞募集：糖胺聚糖相互作用的作用。
Sci Rep. 2016 Sep 14;6:33123. doi: 10.1038/srep33123.
4
Low molecular weight fucoidan modulates P-selectin and alleviates diabetic nephropathy.低分子量岩藻聚糖通过调节 P 选择素缓解糖尿病肾病。
Int J Biol Macromol. 2016 Oct;91:233-40. doi: 10.1016/j.ijbiomac.2016.05.081. Epub 2016 May 24.
5
Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3.CCL5和CCL3寡聚化及与糖胺聚糖结合的结构基础
Proc Natl Acad Sci U S A. 2016 May 3;113(18):5000-5. doi: 10.1073/pnas.1523981113. Epub 2016 Apr 18.
6
CXCL1/MGSA Is a Novel Glycosaminoglycan (GAG)-binding Chemokine: STRUCTURAL EVIDENCE FOR TWO DISTINCT NON-OVERLAPPING BINDING DOMAINS.CXCL1/MGSA是一种新型的糖胺聚糖（GAG）结合趋化因子：两个不同且不重叠结合域的结构证据。
J Biol Chem. 2016 Feb 19;291(8):4247-55. doi: 10.1074/jbc.M115.697888. Epub 2015 Dec 31.
7
The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization.趋化因子-糖胺聚糖相互作用对趋化因子寡聚化的依赖性。
Glycobiology. 2016 Mar;26(3):312-26. doi: 10.1093/glycob/cwv100. Epub 2015 Nov 17.
8
Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions.趋化因子CXCL8/IL-8单体和二聚体与糖胺聚糖结合的溶液核磁共振表征：结构可塑性介导不同的结合相互作用。
Biochem J. 2015 Nov 15;472(1):121-33. doi: 10.1042/BJ20150059. Epub 2015 Sep 14.
9
The Interaction of Heparin Tetrasaccharides with Chemokine CCL5 Is Modulated by Sulfation Pattern and pH.硫酸化模式和pH对肝素四糖与趋化因子CCL5相互作用的调节作用
J Biol Chem. 2015 Jun 19;290(25):15421-15436. doi: 10.1074/jbc.M115.655845. Epub 2015 Apr 23.
10
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans.蛋白聚糖的形式与功能：蛋白聚糖的综合命名法。
Matrix Biol. 2015 Mar;42:11-55. doi: 10.1016/j.matbio.2015.02.003. Epub 2015 Feb 18.
Zotero 插件